*Refresh the page if the below document does not appear.
US FDA approves Alembic Pharma's generic version of Glycopyrrolate injection
On Tuesday, Alembic Pharmaceuticals announced that it has received final approval for the ANDA (Abbreviated New Drug Application) for its new generic drug Glycopyrrolate injection used as pre-operative medication to inhibit salivary gland and respiratory secretions.
India's Sun Pharma shows a surprize increase in Q2 profit
Sun Pharmaceutical Industries Limited, India’s largest drug manufacturing company, on Tuesday announced a surprise 10.5% hike in the second quarter profit which was followed by a surge in sales of specialty drugs.
Advent International launches new brand for its API and CDMO platform
The private equity investor announced in a press release, the launch of Cohance Lifesciences that would help in establishing a whole new brand identity for the API and CDMO platform to show its vision and operating philosophy in a better way.
Solara Active Pharma Sciences Vizag facility gets CEP approval to manufacture Ibuprofen API
The Active Pharmaceutical Ingredient provider, Solara Active Pharma Sciences Ltd. declared that that its new multipurpose API manufacturing facility at Vizag in Andhra Pradesh, has received the CEP (Certificate of Suitability) for the manufacture of Ibuprofen API, from European Directorate for the Quality of Medicines (EDQM).
Supply chain expert warns drug shortages not going away anytime soon
According to Bindiya Vakil, CEO of a California-based supply-chain solutions expert named ‘Resilinc’ catering to a variety of industries, all the well-documented shortages of drugs aren’t going away any time soon.
US CDC director gets rebound COVID-19 infection after Pfizer's Paxlovid treatment
The director of the US CDC (Centers for Disease Control and Prevention), Rochelle Walensky underwent Paxlovid pills treatment after she was found to be COVID positive. After the treatment and a period of isolation she was tested to be COVID negative but was found to be positive again this Sunday.
Dr. Reddy's now amongst the top 20 Pharma employers
Dr. Reddy’s Laboratories Limited reported that a very prestigious publication “Science” has named the company in its Top 20 employers list in pharma, biotechnology and biopharma for 2022.